Sl. Ma et al., EXPRESSION AND CHARACTERIZATION OF A DIVALENT CHIMERIC ANTI-HUMAN CD3SINGLE-CHAIN ANTIBODY, Scandinavian journal of immunology, 43(2), 1996, pp. 134-139
Murine anti-CD3 monoclonal antibodies (MoAbs) are used in clinical pra
ctice for immunosuppression. However, there are two major drawbacks to
this treatment: the associated cytokine release syndrome and human an
ti-mouse antibody response. To overcome these side-effects, the author
s generated a chimeric anti-human CD3 single chain antibody, scUCHT1.
It is an IgM variant of UCHT1, a mouse IgG1 MoAb directed against huma
n CD3. scUCHT1 consists of the light and heavy variable chain binding
domains of UCHT1 and a human IgM Fc region (CH2 to CH4), scUCHT1 was p
roduced by COS-7 and SP2/0 transfectants, and mainly assembled in a di
meric form. It retained the binding specificity and affinity of the pa
rental MoAb UCHT1. In contrast to UCHT1, scUCHT1 did not induce T-cell
proliferation and cytokine release (TNF-alpha and IFN-gamma) in in vi
tro assays. These results suggest that the engineered chimeric anti-CD
3 single chain antibody (scUCHT1) may be useful in clinical immunosupp
ressive treatment.